Safely Reduce Cystoscopic Evaluations for Hematuria Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorErasmus Medical Center
About this trial
The SeARCH-trial assess the clinical impact of a molecular urine test as a 'urine-first' strategy in the diagnostic workup of patients presenting with microscopic hematuria.
Eligibility criteria
Qualifiers
Microscopically confirmed microscopic hematuria of voided urine defined as ≥3 erythrocytes per high power field
Male patients ≥40 years
Female patients ≥50 years
Disqualifiers
History of urothelial bladder- or urinary tract cancer
Presence of macroscopic (visible) hematuria
Woman who is or may be pregnant
Trial design
Treatments tested in this trial
- urine-first strategy
Treatment groups
1,100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov